Survey Confirms Patients Find Greater Comfort, Improved Safety and Enhanced Personal Appearance with Uni-flo2 Single-Nasal Cannula System, Significant Impact for COPD

LEHIGH VALLEY, Pa.--(BUSINESS WIRE)-- Uni-flo2 Single-nasal Cannula System (Uni-flo2), a breakthrough patient-centric solution that ensures continuous oxygen flow equivalent to the low flow dual-pronged cannula but with half the skin contact, reports the positive responses from a patient satisfaction survey, with 98 percent finding Uni-flo2 to be more comfortable, stable and secure. Among the advantages most frequently cited by COPD patients are:
  • Greater comfort
  • Freedom of movement
  • Avoidance of facial skin irritation
  • Improved sleep
  • Ease of eating
  • Enhanced ability to smell
  • Enhanced personal appearance.

“With the vast number of COPD patients struggling to breathe and requiring low flow supplemental oxygen, the introduction of the Uni-flo2 discreet, lightweight single cannula is a welcome life-changing enhancement that optimizes oxygen absorption and improves health,” says Campbell Cauthen, Registered Respiratory Therapist and co-inventor, UPODS LLC, developers and marketers of Uni-flo2.“Placement of the soft-design Uni-flo2 on just one side of the face eliminates opportunity for skin chafing that can lead to infection, and makes it easier for people to move around more freely. The safety and ease-of-wear benefits – in addition to the cosmetic appeal of a single cannula – promote patient compliance with treatment prescriptions.”

Uni-flo2 conforms to facial contours to eliminate chafing, facial or neck abrasion. Interchangeable to either nostril with multiple strain-relief positions that ensure gas flow, Uni-flo2 reduces tube tugging or pulling on the patient.

Mike M. of Wichita Falls, Texas, says, “Uni-flo2 is perfect for my challenge with COPD. I am missing cartilage in my right ear so I can’t use a two-prong cannula without taping it on. Uni-flo2 Single-Nasal Cannula System gives me the pulse oximetry I need and increased comfort.”

About Uni-flo2

Developed, manufactured and distributed by UPODS LLC., the Uni-flo2 Single Nasal Cannula is lightweight, eliminates half the skin contact and opportunity for infection, and improves patient freedom of movement, comfort, eating, sleeping and personal appearance. Uni-flo2 conforms to all facial contours with a strain relief system that ensures continuous oxygen flow equivalent to the dual-pronged cannula. Designed with patient dignity, comfort and safety in mind for home care specialists, clinicians, assisted living facilities, hospitals and other healthcare providers. Uni-flo2 holds Patent No. 9,440,039 and Patent No. 9,925,348. Visit



CPR Communications for Uni-flo2
Brittany Tedesco, 201-641-1911 x 14




Back to news